Baltimore Vaccine Plant’s Troubles Ripple Across Africa, Europe and Canada

The New York Times | May 6, 2021, 2:52 p.m. | Original

Millions of doses of Johnson & Johnson’s Covid-19 vaccine produced by Emergent BioSolutions have been held back in Europe, South Africa and Canada as a precaution.

Second Time Lucky? Eurovision Hopefuls Try Again. Germany to Open AstraZeneca Vaccine to Everyone 18 and Older